Delivery Order SPE2DB20D1109-SPE2DB21FP06J

Award Date 4/20/21
Potential Completion Date 4/21/21
Potential Value $2.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chesterbrook, PA, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,240.76 Firm Fixed Price Delivery Order covers the supply of 4,556,883,698 units of Oxycodone HCL (IR) 5 mg tablets in 100-count bottles. This delivery order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which provides a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of oxycodone-acetaminophen 10-325 mg tablets. The $1,024.88 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price valued at $1,347.18. The award was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,564,167,843 units of Oxycodone HCl (IR) 5 mg tablets. The contract has an ultimate completion date of March 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,702.34 firm-fixed-price delivery order is for the supply of 4,562,053,279 tablets of the opioid medication Oxycontin ER 10 mg. The award has a completion date of September 6, 2023 and was made without any set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,537.01 firm fixed price delivery order is for 4,563,348,058 units of Oxycodone Hydrochloride 5 mg tablets. This award is part of Amerisourcebergen's existing indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities. No set-aside designation was used...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,476.76 delivery order contract covers the supply of 4,566,456,182 tablets of 5 mg Oxycodone HCL, an immediate-release opioid pain medication. The contract has a completion date of November 18, 2024 and uses a firm fixed-price pricing type. This award is not associated with a set-aside program. Amerisourcebergen...
This federal contract award, valued at $1,368.12, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,522.14 for the supply of Oxycontin ER 20 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, and has an ultimate completion date of March 10, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves...
This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,166.60 firm fixed-price delivery order is for the supply of 4,566,556,083 units of Oxycodone HCl (IR) 5 mg tablets in 100-count bottles, with a completion date of November 27, 2024. AmerisourceBergen is the prime contractor and no set-aside designation was used for this award. This delivery order is part of a larger...
The Defense Logistics Agency (DLA) awarded a $2,855.92 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,564,569,584 units of 5mg/5ml Oxycodone HCl oral solution. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a wide range of pharmaceutical and medical products to support the Department of Defense worldwide. Amerisourcebergen, a...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB21FP06J
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,920.26 firm fixed-price delivery order is for the supply of 4,553,237,348 units of Oxycodone Hydrochloride 5 mg tablets. The award is not associated with a set-aside program.

Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These contracting mechanisms enable efficient government procurement of essential medications and medical equipment to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 10:03 AM